{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:32:18Z","timestamp":1772159538827,"version":"3.50.1"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered by the lack of data about the underlying immune alterations, a controversy existing on whether it is a unique diagnostic entity <jats:italic>vs<\/jats:italic>. a subtype of Common Variable Immune Deficiency (CVID).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we used high-sensitive flow cytometry to investigate the distribution of up to 70 different immune cell populations in blood of GS patients (n=9) compared to age-matched CVID patients (n=55) and healthy donors (n=61).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All 9 GS patients displayed reduced B-cell counts -down to undetectable levels (&amp;lt;0.1 cells\/\u03bcL) in 8\/9 cases-, together with decreased numbers of total CD4<jats:sup>+<\/jats:sup> T-cells, NK-cells, neutrophils, and basophils <jats:italic>vs.<\/jats:italic> age-matched healthy donors. In contrast, they showed expanded TCR\u03b3\u03b4<jats:sup>+<\/jats:sup> T-cells (p \u2264 0.05). Except for a deeper B-cell defect, the pattern of immune cell alteration in blood was similar in GS and (age-matched) CVID patients. In depth analysis of CD4<jats:sup>+<\/jats:sup> T-cells revealed significantly decreased blood counts of na\u00efve, central memory (CM) and transitional memory (TM) TCD4<jats:sup>+<\/jats:sup> cells and their functional compartments of T follicular helper (TFH), regulatory T cells (Tregs), T helper (Th)2, Th17, Th22, Th1\/Th17 and Th1\/Th2 cells. In addition, GS patients also showed decreased NK-cell, neutrophil, basophil, classical monocyte and of both CD1c<jats:sup>+<\/jats:sup> and CD141<jats:sup>+<\/jats:sup> myeloid dendritic cell counts in blood, in parallel to an expansion of total and terminal effector TCR\u03b3\u03b4<jats:sup>+<\/jats:sup> T-cells. Interestingly, those GS patients who developed hypogammaglobulinemia several years after the thymoma presented with an immunological and clinical phenotype which more closely resembled a combined immune humoral and cellular defect, with poorer response to immunoglobulin replacement therapy, as compared to those in whom the thymoma and hypogammaglobulinemia were simultaneously detected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings provide a more accurate definition of the immune cell defects of GS patients and contribute to a better discrimination among GS patients between those with a pure B-cell defect <jats:italic>vs<\/jats:italic>. those suffering from a combined immunodeficiency with important consequences on the diagnosis and management of the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1285088","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:39:43Z","timestamp":1700041183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["In-depth blood immune profiling of Good syndrome patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Alba","family":"Torres-Valle","sequence":"first","affiliation":[]},{"given":"Larraitz","family":"Aragon","sequence":"additional","affiliation":[]},{"given":"Susana L.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Serrano","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Marcos","sequence":"additional","affiliation":[]},{"given":"Josefa","family":"Melero","sequence":"additional","affiliation":[]},{"given":"Carolien","family":"Bonroy","sequence":"additional","affiliation":[]},{"given":"Pedro Pablo","family":"Arenas-Caro","sequence":"additional","affiliation":[]},{"given":"David Monzon","family":"Casado","sequence":"additional","affiliation":[]},{"given":"Pedro Mikel Requejo","family":"Olaizola","sequence":"additional","affiliation":[]},{"given":"Jana","family":"Neirinck","sequence":"additional","affiliation":[]},{"given":"Mattias","family":"Hofmans","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"de Arriba","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda","family":"Jara","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Prieto","sequence":"additional","affiliation":[]},{"given":"Ana E.","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"\u00c1lvaro","family":"Prada","sequence":"additional","affiliation":[]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[]},{"given":"Mart\u00edn","family":"P\u00e9rez-Andr\u00e9s","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"B1","first-page":"1","article-title":"A gammaglobulinemia-A provocative experiment of nature","volume":"26","author":"Good","year":"1954","journal-title":"Bull Univ Minn Hosp Minn Med Fdn"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good\u2019s syndrome remains a mystery after 55 years: A systematic review of the scientific evidence","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.679556","article-title":"When the good syndrome goes bad: A systematic literature review","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/ICB.0000000000001316","article-title":"Good Syndrome: Cytomegalovirus retinitis case challenge","volume":"11","author":"Baquero-Ospina","year":"2022","journal-title":"Retin cases Brief Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908453","article-title":"Immunological signature of patients with thymic epithelial tumors and Good syndrome","volume":"13","author":"Malfitano","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.11.021","article-title":"Non-infectious gastrointestinal manifestations of Good syndrome","volume":"109","author":"Wang","year":"2023","journal-title":"Eur J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.12.040","article-title":"Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review","volume":"129","author":"Wee","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"AB80","DOI":"10.1016\/j.jaci.2022.12.252","article-title":"Thinking beyond hypogammaglobinemia is a good strategy in good syndrome","volume":"151","author":"D\u2019Netto","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.48729\/PJCTVS.313","article-title":"Goods\u2019s syndrome: immunodeficiency beyond thymectomy","volume":"30","author":"Queir\u00f3s Gomes","year":"2023","journal-title":"Port J Card Thorac Vasc Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03431-5","article-title":"Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression","volume":"72","author":"Furuya","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061605","article-title":"Insights from a case of good\u2019s syndrome (Immunodeficiency with thymoma)","volume":"11","author":"Paganelli","year":"2023","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-023-01542-3","article-title":"Inborn errors of immunity\u2014the Sri Lankan experience 2010\u20132022","volume":"1","author":"Dasanayake","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202211-2159IM","article-title":"Good\u2019s syndrome: thymoma with acquired immunodeficiency","volume":"208","author":"Koo","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cgh.2022.07.030","article-title":"Genetic diagnosis guides treatment of autoimmune enteropathy","volume":"21","author":"Charbit-Henrion","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/med-22-12","article-title":"Good\u2019s syndrome and COVID-19: case report and literature review","volume":"7","author":"Berzenji","year":"2023","journal-title":"Mediastinum"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.815710","article-title":"Good\u2019s syndrome: time to move on from reviewing the past","volume":"12","author":"Kabir","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ269","article-title":"Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications","volume":"61","author":"Malphettes","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2016.04.002","article-title":"Thymectomy for myasthenia gravis: complete stable remission and associated prognostic factors in over 1000 cases","volume":"28","author":"Kaufman","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20595","article-title":"Persistence of immunological alterations after thymectomy in Good\u2019s syndrome: A clue to its pathogenesis","author":"Ternavasio-de la Vega","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.07.025","article-title":"Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective","volume":"171","author":"Jansen","year":"2016","journal-title":"Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/CEI.13216","article-title":"Clinical and laboratory features of seventy-eight UK patients with Good\u2019s syndrome (thymoma and hypogammaglobulinaemia)","volume":"195","author":"Zaman","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.1999.00109.x","article-title":"Primary immunodeficiency diseases report of an IUIS scientific committee","volume":"118","author":"Rosen","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1347","article-title":"Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005","volume":"117","author":"Notarangelo","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00246","article-title":"The euroFlow PID orientation tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system","volume":"10","author":"van der Burg","year":"2019","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00166","article-title":"Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-color euroFlow immune monitoring tube","volume":"11","author":"Botafogo","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935879","article-title":"Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood","volume":"13","author":"van der Pan","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B30","unstructured":"AbinunM\n            AlbertM\n            Beaussant CohenS\n            BucklandM\n            BustamanteJ\n            CantA\n          European Society for ImmunodeficienciesESID Registry-Working definitions for clinical diagnosis of IEI ESID Registry-Working Definitions for Clinical Diagnosis of PID"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01271","article-title":"EuroFlow-based flowcytometric diagnostic screening and classification of primary immunodeficiencies of the lymphoid system","volume":"10","author":"van Dongen","year":"2019","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584646","article-title":"Improved standardization of flow cytometry diagnostic screening of primary immunodeficiency by software-based automated gating","volume":"11","author":"Linskens","year":"2020","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937738","article-title":"The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital","volume":"13","author":"Neirinck","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666953","article-title":"Highly sensitive flow cytometry allows monitoring of changes in circulating immune cells in blood after tdap booster vaccination","volume":"12","author":"Diks","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Package ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.02.017","article-title":"Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies","volume":"144","author":"Blanco","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The\u00a02021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00479.x","article-title":"Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-\u03b3) in CD28+ (\u2018cytotoxic\u2019) and CD28\u2013 (\u2018suppressor\u2019) CD8+ subsets","volume":"111","author":"North","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2017.70966","article-title":"Terminally differentiated memory T cells are increased in patients with common variable immunodeficiency and selective IgA deficiency","volume":"42","author":"Nechvatalova","year":"2017","journal-title":"Cent Eur J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The TH1 phenotype of follicular helper T cells indicates an IFN-\u03b3\u2013associated immune dysregulation in patients with CD21low common variable immunodeficiency","volume":"141","author":"Unger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02593","article-title":"Predominantly antibody-deficient patients with non-infectious complications have reduced naive B, treg, th17, and tfh17 cells","volume":"10","author":"Edwards","year":"2019","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200103000-00005","article-title":"Infections in patients with immunodeficiency with thymoma (Good syndrome)","volume":"80","author":"Tarr","year":"2001","journal-title":"Medicine"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60695-3","article-title":"Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature","volume":"98","author":"Agarwal","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3133","article-title":"Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells","volume":"24","author":"Hon","year":"2006","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00000441-200401000-00011","article-title":"Successful treatment of good syndrome with cytomegalovirus duodenoenteritis using a combination of ganciclovir and immunoglobulin with high anti-cytomegalovirus antibody titer","volume":"327","author":"Koriyama","year":"2004","journal-title":"Am J Med Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1983.tb01361.x","article-title":"Acquired basophil and eosinophil deficiency in a patient with hypogammaglobulinaemia associated with thymoma","volume":"5","author":"Mitchell","year":"1983","journal-title":"Clin Lab Haematol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1745-7580.10000119","article-title":"Role of chemokine signalling in the pathogenesis of good\u2019s syndrome-case reports, clinical characterization from single-centre perspective","volume":"12","author":"Zdziarski","year":"2016","journal-title":"Immunome Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2009.207308","article-title":"Lichen planus in a case of Good\u2019s syndrome (thymoma and immunodeficiency)","volume":"9","author":"Khan","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.10.2046.2046","article-title":"Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features","volume":"76","author":"Wright","year":"1990","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.07.006","article-title":"Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency","volume":"141","author":"Kuntz","year":"2011","journal-title":"Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.07.002","article-title":"Exclusion of patients with a severe T-cell defect improves the definition of common variable immunodeficiency","volume":"4","author":"Bertinchamp","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2019.04.001","article-title":"Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency","volume":"203","author":"von Spee-Mayer","year":"2019","journal-title":"Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01291-9","article-title":"Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency","volume":"42","author":"Klocperk","year":"2022","journal-title":"J Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.046","article-title":"Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency","volume":"146","author":"Hultberg","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.06.012","article-title":"Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses","volume":"143","author":"Romberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13164","article-title":"Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects","volume":"96","author":"Tofighi Zavareh","year":"2022","journal-title":"Scand J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2012.07.014","article-title":"TACI mutation in Good\u2019s Syndrome: In search of a genetic basis","volume":"145","author":"S\u00e1enz-Cuesta","year":"2012","journal-title":"Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02502","article-title":"Complete multilineage CD4 expression defect associated with warts due to an inherited homozygous CD4 gene mutation","volume":"10","author":"Fernandes","year":"2019","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2009.07.002","article-title":"Immunophenotypic abnormalities of CD8+ T-cell subsets in a patient with unusual Good\u2019s Syndrome","volume":"38","author":"Del Pozo","year":"2010","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12239","article-title":"Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9","volume":"175","author":"Taraldsrud","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.03.019","article-title":"Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells","volume":"24","author":"Wang","year":"2006","journal-title":"Immunity"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03176","article-title":"Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy","volume":"9","author":"Patente","year":"2019","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody\u2013associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2020.12.010","article-title":"Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin","volume":"231","author":"Guevara-Hoyer","year":"2021","journal-title":"Immunol Lett"},{"key":"B71","article-title":"Thymoma and hypogammaglobulinaemia with and without T suppressor cells","volume":"58","author":"Brenner","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J\u00a0Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1285088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:39:58Z","timestamp":1700041198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1285088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2023.1285088"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1285088","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"article-number":"1285088"}}